ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPGN OpGen Inc

0.515
-0.017 (-3.20%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
OpGen Inc NASDAQ:OPGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.017 -3.20% 0.515 0.4179 1.31 0.552 0.48 0.54 437,254 05:00:10

Amended Statement of Changes in Beneficial Ownership (4/a)

25/07/2017 10:54pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

jVen Capital, LLC
2. Issuer Name and Ticker or Trading Symbol

OPGEN INC [ OPGN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman and CEO
(Last)          (First)          (Middle)

11009 CRIPPLEGATE ROAD, 
3. Date of Earliest Transaction (MM/DD/YYYY)

7/5/2017
(Street)

POTOMAC, MD 20854
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

7/10/2017 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants to purchase Common Stock   (1) $0.69   (2) 7/5/2017     P      158730       12/5/2017   7/5/2022   (2) Common Stock   158730   $0.00   158730   D   (3)  

Explanation of Responses:
(1)  Issuance of warrants pursuant to that certain Amended & Restated Note Purchase Agreement dated July 10, 2017.
(2)  The purpose of this Form 4/A is to correct the exercise price and expiration date for this warrant issuance.
(3)  Evan Jones, the Chairman of the Board and the Chief Executive Officer of OpGen, Inc. (the "Company"), is the managing member of jVen Capital, LLC and is the indirect beneficial owner of all shares of the Company's Common Stock owned by jVen Capital, LLC.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
jVen Capital, LLC
11009 CRIPPLEGATE ROAD
POTOMAC, MD 20854
X X Chairman and CEO
JONES EVAN/ FA
C/O OPGEN, INC.
708 QUINCE ORCHARD ROAD, SUITE 160
GAITHERSBURG, MD 20878


Chief Executive Officer

Signatures
/s/ Timothy C. Dec, Attorney-in-Fact 7/25/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year OpGen Chart

1 Year OpGen Chart

1 Month OpGen Chart

1 Month OpGen Chart

Your Recent History

Delayed Upgrade Clock